{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-019257","form_type":"8-K","ticker":"CTMX","cik":"0001501989","company_name":"CytomX Therapeutics, Inc.","filed_at":"2025-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.813248+00:00","generated_at":"2026-05-27T03:57:38.502353+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CytomX CBO Jeffrey Landau to depart effective Feb 7, 2025","bullets":["Jeffrey Landau, SVP, Chief Business Officer, and Head of Strategy, will leave the company on February 7, 2025.","Separation agreement provides economic payments consistent with existing severance and change of control agreement.","Separation includes a general release of claims against the company.","No replacement for Landau's role has been announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-019257","json":"https://secwatch.observer/filing/0001193125-25-019257.json","markdown":"https://secwatch.observer/filing/0001193125-25-019257.md","text":"https://secwatch.observer/filing/0001193125-25-019257.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501989/000119312525019257/0001193125-25-019257-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501989/000119312525019257/d924316d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T03:57:38.502353+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0a3651eab5","claim":"Jeffrey Landau was terminated as Senior Vice President, Chief Business Officer, and Head of Strategy at CytomX Therapeutics, Inc..","evidence_excerpt":"On January 30, 2025, Jeffrey Landau, Senior Vice President, Chief Business Officer, and Head of Strategy, of CytomX Therapeutics, Inc. (the “Company”) and the Company agreed that Mr. Landau’s employment by the Company would terminate, effective February 7, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501989/000119312525019257/0001193125-25-019257-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Senior Vice President, Chief Business Officer, and Head of Strategy"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}